Evoke Pharma (EVOK) Tops Q2 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Evoke Pharma (EVOK) Tops Q2 EPS by 8c

Evoke Pharma Reports Second Quarter 2015 Results

August 13, 2015 4:05 PM EDT

Enrolled 130 total subjects in Phase 3 clinical trial through end of July

Recent FDA draft guidance of advice on Gastroparesis mirrors Evoke's Phase 3 clinical trial protocol design

SOLANA BEACH, Calif., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the second quarter ended June 30, 2015.

Dave Gonyer, R.Ph., President and CEO, stated, "Entering the second half of the year, we continue... More